The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 210 participants.
Also called NCT04408430
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 210 participants
- Sponsor
- Mayra Guerrero
- Registry
-
NCT04408430
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Mexico
- Registry status
- Recruiting
Technical summary
Registry record NCT04408430. Non-randomized; no masking; primary purpose treatment. Start 2021-03-08 (actual); primary completion 2026-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
- Acronym
- MITRAL-II
- Condition
- Mitral Annular Calcification
- Condition
- Mitral Stenosis
- Condition
- Mitral Regurgitation
- Condition
- Mitral Valve Disease
- Intervention (Device)
- Transseptal ViMAC
- Lead sponsor
- Mayra Guerrero
Record details
- Record id
cardio:ct-nct04408430- Content hash
e6ea7319c5b2cffe06ec97bf7932ee127947c4b5690bb46edc2d1f3b75cdced9